India's Venus Seeks U.S. Partner For New Antibiotic Against Resistance
This article was originally published in PharmAsia News
Executive Summary
India's Venus Remedies said it wants to team with U.S.-based drug firm to develop and market Elores, an antibiotic adjuvant targeting pathogens that foster resistance.